Oncology emerges as dominant therapy area for CRISPR technology
In late 2023, the Medicines and Healthcare products Regulatory Agency approved Vertex’s Casgevy, which became the inaugural clustered regularly interspaced...
In late 2023, the Medicines and Healthcare products Regulatory Agency approved Vertex’s Casgevy, which became the inaugural clustered regularly interspaced...
May 2, 2024 — GE HealthCare has announced a new radiation therapy computed tomography (CT) solution with innovative hardware and...